The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.
Author(s): Mengod G, Charli JL, Palacios JM
Publication: Cell Mol Neurobiol, 1990, Vol. 10, Page 113-26
PubMed ID: 2334944 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to examine the effect of PMI (5.5-15 h), patient age (42-82 y), gender and Huntington's or Parkinson's disease on the levels of neuropeptide transcripts by ISH and northern blot. Specimens from 12 control and 6 Huntington's disease patients were used for analysis.
Summary of Findings:
No significant effects of patient age, gender or PMI on the optical density of the ISH signal from preproenkephalin A, somatostatin or neuropeptide Y was observed in the three regions of striatum. Striatum allowed for observation of preproenkephalin A, somatostatin, neuropeptide Y, but not cholecystokinin, arginine-vasopressin and oxytocin. In the hypothalamus, preproenkephalin A, somatostatin, oxytocin and arginine- vasopressin were observed. Huntington's and Parkinson's disease resulted in decreased preproenkephalin A, but not somatostatin or neuropeptide Y. The authors conclude that neuropeptide transcript levels may be examined by ISH or northern blot in postmortem tissue even after a PMI of 15 h and while brain region and disease specific differences occur there was no effect of gender or age.
Biospecimens
Preservative Types
- Frozen
Diagnoses:
- Cardiovascular Disease
- Huntington's Disease
- Parkinson's Disease
- Autopsy
Platform:
Analyte Technology Platform RNA In situ hybridization RNA Northern blot Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Preaquisition Postmortem interval 5.5 h
6.5 h
8.5 h
14.5 h
15 h
Preaquisition Patient age 42 y
62 y
77 y
82 y
Preaquisition Patient gender Female
Male
Biospecimen Acquisition Biospecimen location Striatum-caudate
Striatum-putamen
Striatum-accumbens
Hypothalamus
In situ hybridization Specific Targeted nucleic acid Preproenkephalin A
Somatostatin
Neuropeptide Y
Preaquisition Diagnosis/ patient condition Huntington's disease
Parkinson's disease
No neuropsychiatric disorder